Genentech recently issued an SMA community statement highlighting updates from the 2023 SMA Research & Clinical Care Meeting.
These updates included:
- Investigating risdiplam treatment post gene-therapy
- Long-term efficacy and safety of risdiplam
- Real-world evidence generation
Check out the full community statement here.